PI
PineBridge Investments’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-9,837
| Closed | -$608K | – | 848 |
|
|
2019
Q4 | $608K | Sell |
9,837
-5,475
| -36% | -$338K | 0.01% | 817 |
|
|
2019
Q3 | $920K | Buy |
15,312
+1,277
| +9% | +$76.7K | 0.01% | 784 |
|
|
2019
Q2 | $1.18M | Buy |
14,035
+10,115
| +258% | +$853K | 0.02% | 602 |
|
|
2019
Q1 | $374K | Buy |
3,920
+67
| +2% | +$6.39K | 0.01% | 754 |
|
|
2018
Q4 | $273K | Buy |
3,853
+423
| +12% | +$30K | 0.01% | 806 |
|
|
2018
Q3 | $293K | Buy |
3,430
+954
| +39% | +$81.5K | 0.01% | 841 |
|
|
2018
Q2 | $287K | Sell |
2,476
-397
| -14% | -$46K | 0.01% | 809 |
|
|
2018
Q1 | $232K | Buy |
+2,873
| New | +$232K | 0.01% | 867 |
|
|
2017
Q4 | – | Sell |
-1,772
| Closed | -$82K | – | 1073 |
|
|
2017
Q3 | $82K | Sell |
1,772
-58
| -3% | -$2.68K | ﹤0.01% | 978 |
|
|
2017
Q2 | $66K | Sell |
1,830
-21,855
| -92% | -$788K | ﹤0.01% | 986 |
|
|
2017
Q1 | $729K | Buy |
23,685
+7,825
| +49% | +$241K | 0.02% | 586 |
|
|
2016
Q4 | $531K | Buy |
15,860
+14,093
| +798% | +$472K | 0.02% | 628 |
|
|
2016
Q3 | $47K | Buy |
1,767
+227
| +15% | +$6.04K | ﹤0.01% | 975 |
|
|
2016
Q2 | $34K | Hold |
1,540
| – | – | ﹤0.01% | 1012 |
|
|
2016
Q1 | $45K | Sell |
1,540
-218
| -12% | -$6.37K | ﹤0.01% | 938 |
|
|
2015
Q4 | $58K | Buy |
1,758
+275
| +19% | +$9.07K | ﹤0.01% | 909 |
|
|
2015
Q3 | $54K | Buy |
+1,483
| New | +$54K | ﹤0.01% | 912 |
|